| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $185K | -84.6% |
| SG&A Expense | $8.8M | +109.8% |
| Operating Income | -$13.2M | -129.1% |
| Interest Expense | $989K | — |
| Pre-tax Income | -$17.0M | -175.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$17.0M | -171.1% |
| EPS (Basic) | -$8.11 | +53.8% |
| EPS (Diluted) | -$8.11 | +53.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.3M | +1545.9% |
| Current Assets | $31.0M | +560.8% |
| Total Assets | $31.3M | +567.4% |
| Current Liabilities | $3.3M | +65.8% |
| Stockholders' Equity | $28.0M | +943.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -9.9% |
| Investing Cash Flow | -$15.9M | -732.6% |
| Financing Cash Flow | $41.0M | +355.1% |